A Longitudinal, 3-Month Serologic Assessment of SARS-CoV-2 Infections in a Belgian Hemodialysis Facility.
作者信息
Labriola Laura, Scohy Anaïs, Seghers François, Perlot Quentin, De Greef Julien, Desmet Christine, Romain Cécile, Morelle Johann, Yombi Jean-Cyr, Kabamba Benoît, Rodriguez-Villalobos Hector, Jadoul Michel
机构信息
Department of Nephrology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium.
Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.
出版信息
Clin J Am Soc Nephrol. 2021 Apr 7;16(4):613-614. doi: 10.2215/CJN.12490720. Epub 2020 Nov 18.
Abstract
摘要
相似文献
1
A Longitudinal, 3-Month Serologic Assessment of SARS-CoV-2 Infections in a Belgian Hemodialysis Facility.比利时一家血液透析机构中SARS-CoV-2感染的3个月纵向血清学评估
Clin J Am Soc Nephrol. 2021 Apr 7;16(4):613-614. doi: 10.2215/CJN.12490720. Epub 2020 Nov 18.
2
Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection.感染后长达10个月的新型冠状病毒2抗体反应动态。
Cell Mol Immunol. 2021 Jul;18(7):1832-1834. doi: 10.1038/s41423-021-00708-6. Epub 2021 Jun 7.
3
Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit.儿科透析病房中SARS-CoV-2的纵向血清转化及功能异质性
Kidney Int. 2021 Feb;99(2):484-486. doi: 10.1016/j.kint.2020.11.014.
4
Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.新型冠状病毒感染康复者血清特异性 IgG 抗体持久性及其与临床症状和疾病严重程度的关系：一项前瞻性纵向队列研究。
Int Immunopharmacol. 2021 Sep;98:107893. doi: 10.1016/j.intimp.2021.107893. Epub 2021 Jun 16.
5
Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.智利一家三级医院在新冠疫情第一波期间对一线医护人员的 SARS-CoV-2 IgG 血清阳转进行的纵向评估。
BMC Infect Dis. 2021 May 26;21(1):478. doi: 10.1186/s12879-021-06208-2.
6
Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease.免疫抑制的炎症性肠病患者对 COVID-19 感染的体液免疫反应。
Eur J Gastroenterol Hepatol. 2021 Mar 1;33(3):443-447. doi: 10.1097/MEG.0000000000002094.
7
Prolonged SARS-CoV-2 Viral RNA Shedding and IgG Antibody Response to SARS-CoV-2 in Patients on Hemodialysis.血液透析患者中SARS-CoV-2病毒RNA的长期脱落及对SARS-CoV-2的IgG抗体反应
Clin J Am Soc Nephrol. 2021 Feb 8;16(2):290-292. doi: 10.2215/CJN.11120720. Epub 2020 Oct 14.
8
Serological and Molecular Tests for COVID-19: a recent update.血清学和分子检测在 COVID-19 中的应用：最新进展。
Iran J Immunol. 2021 Mar;18(1):13-33. doi: 10.22034/iji.2021.88660.1894.
9
SARS-CoV-2 Antigenemia as a Confounding Factor in Immunodiagnostic Assays: A Case Study.SARS-CoV-2 抗原血症作为免疫诊断检测中的混杂因素：案例研究。
Viruses. 2021 Jun 14;13(6):1143. doi: 10.3390/v13061143.
10
Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2.一项全印血清流行病学调查（Phenome-India 队列）对 SARS-CoV2 的分析。
Elife. 2021 Apr 20;10:e66537. doi: 10.7554/eLife.66537.
引用本文的文献
1
Humoral Response in Hemodialysis Patients Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review of Literature.新冠病毒mRNA疫苗接种后血液透析患者的体液免疫反应：文献系统综述
Vaccines (Basel). 2023 Mar 24;11(4):724. doi: 10.3390/vaccines11040724.
2
Immune response after COVID-19 vaccination among patients with chronic kidney disease and kidney transplant.COVID-19 疫苗接种后慢性肾脏病和肾移植患者的免疫反应。
Vaccine. 2022 Oct 26;40(45):6499-6511. doi: 10.1016/j.vaccine.2022.09.067. Epub 2022 Sep 28.
3
BNT162b2 vaccine effectiveness in chronic kidney disease patients-an observational study.BNT162b2疫苗对慢性肾病患者的有效性——一项观察性研究
Clin Kidney J. 2022 Jul 4;15(10):1838-1846. doi: 10.1093/ckj/sfac166. eCollection 2022 Oct.
4
SARS-CoV-2 in dialysis patients and the impact of vaccination.透析患者中的 SARS-CoV-2 与疫苗接种的影响。
BMC Nephrol. 2022 Sep 21;23(1):317. doi: 10.1186/s12882-022-02940-2.
5
Vaccination against SARS-CoV-2 in Haemodialysis Patients: Spike's Ab Response and the Influence of BMI and Age.血液透析患者的 SARS-CoV-2 疫苗接种：刺突的 Ab 反应以及 BMI 和年龄的影响。
Int J Environ Res Public Health. 2022 Aug 15;19(16):10091. doi: 10.3390/ijerph191610091.
6
ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis.接受维持性血液透析的COVID-19感染患者中ChAdOx1 nCoV-19的免疫原性和免疫反应
Vaccines (Basel). 2022 Jun 16;10(6):959. doi: 10.3390/vaccines10060959.
7
Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.1273-mRNA 新冠病毒疫苗接种后长期血液透析患者中产生强烈细胞和体液免疫应答。
Front Immunol. 2022 Mar 23;13:845882. doi: 10.3389/fimmu.2022.845882. eCollection 2022.
8
SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients.SARS-CoV-2 特异性 T 细胞反应与血液透析患者的再感染无关。
J Am Soc Nephrol. 2022 May;33(5):883-887. doi: 10.1681/ASN.2021121587. Epub 2022 Mar 31.
9
A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.一例 COVID-19 再感染病例：抗体在 SARS-CoV-2 感染中的作用。
CEN Case Rep. 2022 Nov;11(4):422-427. doi: 10.1007/s13730-022-00697-z. Epub 2022 Mar 9.
10
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment.COVID-19 与透析：临床影响、免疫反应、预防和治疗。
Kidney Int. 2022 May;101(5):883-894. doi: 10.1016/j.kint.2022.01.022. Epub 2022 Feb 14.
Zotero 插件